Physician Wealth Advisors
CORT icon

Physician Wealth Advisors’s Corcept Therapeutics CORT Stock Holding History

Physician Wealth Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$692 Hold
6
– – ﹤0.01% 2086
2026
Q2 		$522 Buy
+6
New +$362 ﹤0.01% 2107
2026
Q1 		– Sell
-16
Closed -$557 – 2097
2025
Q4 		$557 Hold
16
– – ﹤0.01% 1828
2025
Q3 		$1.33K Hold
16
– – ﹤0.01% 1410
2025
Q2 		$1.18K Buy
+16
New +$1.16K ﹤0.01% 1287

Other funds holding CORT

Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Physician Wealth Advisors's CORT Position: Q3 2026 in Review

Physician Wealth Advisors held its Corcept Therapeutics (CORT) position steady in Q3 2026 at 6 shares worth $692. The position accounts for ﹤0.01% of the portfolio, ranked #2086.

Physician Wealth Advisors first reported a position in CORT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.33K in Q3 2025. 280 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Physician Wealth Advisors held 6 shares of Corcept Therapeutics worth $692 as of Q3 2026.
  • Physician Wealth Advisors left its Corcept Therapeutics share count unchanged in Q3 2026.
  • Corcept Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2086 holding.
  • Physician Wealth Advisors first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Physician Wealth Advisors's Corcept Therapeutics position peaked at $1.33K in Q3 2025.
  • 280 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.